Gastrointestinal Cancer News

A precision medicine approach to therapy significantly extended survival for patients with pancreatic cancer compared with standard chemotherapy, according to results of a retrospective study published in The Lancet Oncology.

Today is International HPV Awareness Day.

The FDA granted breakthrough device designation to the Elecsys GALAD score to support earlier diagnosis of hepatocellular carcinoma.

All-cause and cancer-specific mortality rates have declined overall among adolescent and young adult cancer survivors during the past 4 decades, according to results of a retrospective study published in Journal of the National Cancer Institute.

I was delighted to see the Cancer Statistics 2020 report from American Cancer Society, indicating a decline of cancer death rates in the 2016 to 2017 time frame (see related article).

Click here to read the Cover Story, “Smoking cessation should be ‘pillar’ of the cancer treatment protocol.”

Tobacco use is the leading preventable cause of cancer, responsible for nearly 30% of cancer-related deaths in the U.S. annually.

The FDA granted fast track designation to ALX148 for the first-line treatment of patients with head and neck squamous cell carcinoma and second-line treatment of patients with HER2-positive gastric or gastroesophageal junction carcinoma, according to a press release from the drug’s manufacturer.

Electrocautery ablation appeared effective for treatment of anal high-grade squamous intraepithelial lesions among people living with HIV, according to results of a retrospective study published in Cancer.

The FDA granted priority review to ripretinib for treatment of advanced gastrointestinal stromal tumors, according to a press release from the agent’s manufacturer.